Article Published 4 Nov 2025 Key Healthcare And Life Sciences Regulatory Updates And Enforcement Trends In 2025 & Beyond United States Food, Drugs, Healthcare, Life Sciences BI Buchanan Ingersoll & Rooney PC
Article Published 4 Nov 2025 Self-Audits In Transactional Due Diligence And Enforcement Contexts – Prepare Your Company United States Environment SJ Steptoe LLP
Article Published 4 Nov 2025 Teva And Prestige Biopharma Enter Licensing Agreement To Commercialize Their Trastuzumab Biosimilar United States Food, Drugs, Healthcare, Life Sciences GP Goodwin Procter LLP
Article Published 3 Nov 2025 Virtual And Digital Health Digest – October 2025 United States Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 31 Oct 2025 CRLs Unveiled: Converting FDA Transparency Into A Market Advantage United States Food, Drugs, Healthcare, Life Sciences AM Alvarez & Marsal
Article Published 30 Oct 2025 Holland & Knight Health Dose: October 28, 2025 United States Food, Drugs, Healthcare, Life Sciences HK Holland & Knight
Article Published 30 Oct 2025 ATA EDGE 2025 Policy Conference United States Food, Drugs, Healthcare, Life Sciences FL Foley & Lardner
Article Published 30 Oct 2025 Replay: Wearables Webinar Series, Part 2: Cybersecurity And Data Privacy Concerns For Wearables (Video) United States Privacy DM Duane Morris LLP
Article Published 29 Oct 2025 NIH New Patent Licensing Policy United States Intellectual Property TC Thompson Coburn LLP
Article Published 29 Oct 2025 AI In Health Care And Biotechnology: Promise, Progress, And Challenges United States Food, Drugs, Healthcare, Life Sciences FL Foley & Lardner
Article Published 28 Oct 2025 Recent Rulings Highlight Risk To Japanese Drugmakers In Settling Pharmaceutical Litigations United States Food, Drugs, Healthcare, Life Sciences JB Jenner & Block
Article Published 28 Oct 2025 Payers, Providers, And Patients – Oh My!: AI In Healthcare – Key Policy Developments And State Laws United States Technology CM Crowell & Moring LLP
Article Published 27 Oct 2025 Xbrane Enters Into Conditional Financing Deal Related To Ranibizumab Biosimilar United States Food, Drugs, Healthcare, Life Sciences GP Goodwin Procter LLP
Article Published 27 Oct 2025 Our Key Takeaways From The 2025 Licensing Executives Society Annual Meeting United States Intellectual Property BS Ballard Spahr LLP
Article Published 24 Oct 2025 Replay: Wearables Webinar Series, Part 1: Update On FDA Regulation On Wearables (Video) United States Food, Drugs, Healthcare, Life Sciences DM Duane Morris LLP
Article Published 24 Oct 2025 AI-Enabled Tech Faces Dual Hurdles In FDA Regulation, Patent Law United States Intellectual Property MG Marshall, Gerstein & Borun LLP
Article Published 23 Oct 2025 Inside The FDA: Insights From Former Regulators United States Food, Drugs, Healthcare, Life Sciences WL WIT Legal
Article Published 22 Oct 2025 Using AI Responsibly: Balancing Innovation With Privacy United States Privacy HI Harness IP
Article Published 22 Oct 2025 Survey On Assessment Of Health And Environmental Hazards And Risks Of Surface-Treated Nanomaterials Will Close October 31, 2025 United States Environment BC Bergeson & Campbell
Article Published 22 Oct 2025 Royalty Monetizations: The "What, Why, When, Who And How" For Universities, Non-Profit Institutions And Life Sciences Companies United States Food, Drugs, Healthcare, Life Sciences FH Foley Hoag LLP